Hot Features
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment ... Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -1.91570881226 | 2.61 | 2.89 | 2.325 | 106782 | 2.5788296 | CS |
| 4 | 0.07 | 2.81124497992 | 2.49 | 5.17 | 2.11 | 1221448 | 2.95264618 | CS |
| 12 | 0.83 | 47.9768786127 | 1.73 | 5.17 | 1.31 | 513755 | 2.71980622 | CS |
| 26 | 2.315 | 944.897959184 | 0.245 | 5.17 | 0.1323 | 375933 | 1.98074084 | CS |
| 52 | 2.2212 | 655.608028335 | 0.3388 | 5.17 | 0.1323 | 2029104 | 0.59642628 | CS |
| 156 | 2.34 | 1063.63636364 | 0.22 | 6.5 | 0.1323 | 1983009 | 1.11852177 | CS |
| 260 | 0.2 | 8.47457627119 | 2.36 | 6.5 | 0.1323 | 1348152 | 1.17433692 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.